首页|人血白蛋白铝离子残留现状分析

人血白蛋白铝离子残留现状分析

扫码查看
目的 探究人血白蛋白中铝离子的出厂值及货架期内残留现状,并重点考察产品使用的玻璃瓶质量提升情况,为该产品的包材使用评价提供参考.方法 采用原子吸收法测定2023年人血白蛋白样品并与2018年人血白蛋白国家抽检研究数据进行比较;通过加速试验比较国内两家药用玻璃瓶中样品铝含量变化,考察玻璃瓶质量.结果 8 家企业2023年铝离子出厂值较2018年明显下降(下降率31%~75%);2023年货架期内国内产品铝残留较 2018 年平均下降 65%;2023 年使用的两种玻璃瓶铝离子释放量较 2018年下降率分别为 78%与 25%.结论 人血白蛋白产品出厂检验和国家抽检铝残留,以及国内两家重点药品包材生产企业玻璃瓶加速试验样品铝残留均下降,说明国产玻璃瓶质量提升,建议生产企业持续关注产品的包材使用与相容性研究.
Analysis of the urrent status of residual aluminum ion in human albumin
Objective To explore the ex-factory value of aluminum ion in human albumin and the the current status of the residual aluminum ions during the shelf period,and focus on the quality improvement of glass bottles used in the products,so as to provide references for the evaluation of the use of packaging materials of the products.Methods The samples of human albumin in 2023 were determined by atomic absorption spectrometry and compared with the national sampling data of human albumin in 2018.The quality of two domestic medicinal glass bottles was investigated by accelerating test to compare the variation of aluminum content in samples.Results The ex-factory values of aluminum ions in 8 enterprises in 2023 decreased significantly compared with those in 2018(the decline rates of 31%-75%).In 2023,the residual aluminum ions of domestic products during the shelf life was 65%lower than that of 2018 on average.Compared with 2018,the aluminum ion release of the two glass bottles used in 2023 decreased by 78%and 25%,respectively.Conclusion Both the residual aluminum ions of human albumin products in factory inspection and national sampling inspection,and the residual aluminum ions in glass bottle accelerated test samples of two domestic key pharmaceutical packaging material manufacturers decreased,indicating that the quality of domestic glass bottles has improved.It is suggested that the production enterprises should continue to pay attention to the use and compatibility of packaging materials.

Human albuminAluminum ionResidueGlass bottleAtomic absorption method

詹栎、曾浩、王文晞、谢育媛

展开 >

湖北省药品监督检验研究院(武汉 430075)

国家药品监督管理局血液制品质量控制重点实验室(武汉 430075)

人血白蛋白 铝离子 残留量 玻璃瓶 原子吸收法

国家药品抽检计划(2023)

2024

中国药师
国家药品监督管理局高级研修学院,武汉医药(集团)股份有限公司

中国药师

CSTPCD
影响因子:0.944
ISSN:1008-049X
年,卷(期):2024.27(3)
  • 15